Seven Eight Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-38,198
| Closed | -$4.34M | – | 394 |
|
|
2024
Q3 | $4.34M | Buy |
38,198
+20,506
| +116% | +$2.44M | 0.39% | 39 |
|
|
2024
Q2 | $2.19M | Sell |
17,692
-24,594
| -58% | -$3.17M | 0.23% | 114 |
|
|
2024
Q1 | $5.58M | Buy |
+42,286
| New | +$5.21M | 0.58% | 32 |
|
|
2023
Q4 | – | Sell |
-115,677
| Closed | -$11.9M | – | 764 |
|
|
2023
Q3 | $11.9M | Buy |
+115,677
| New | +$12.5M | 1.39% | 2 |
|
|
2022
Q1 | – | Sell |
-120,204
| Closed | -$9.21M | – | 637 |
|
|
2021
Q4 | $9.21M | Buy |
+120,204
| New | +$9.57M | 1.65% | 6 |
|
|
2020
Q4 | – | Sell |
-5,974
| Closed | -$473K | – | 549 |
|
|
2020
Q3 | $473K | Sell |
5,974
-4,401
| -42% | -$345K | 0.1% | 351 |
|
|
2020
Q2 | $766K | Sell |
10,375
-19,807
| -66% | -$1.49M | 0.56% | 35 |
|
|
2020
Q1 | $2.22M | Sell |
30,182
-6,689
| -18% | -$526K | 0.57% | 45 |
|
|
2019
Q4 | $3.2M | Buy |
36,871
+23,161
| +169% | +$1.9M | 0.17% | 185 |
|
|
2019
Q3 | $1.1M | Sell |
13,710
-194,928
| -93% | -$15.6M | 0.06% | 412 |
|
|
2019
Q2 | $16.7M | Buy |
208,638
+190,946
| +1,079% | +$14.6M | 0.88% | 12 |
|
|
2019
Q1 | $1.4M | Buy |
+17,692
| New | +$1.32M | 0.07% | 306 |
|
|
2018
Q3 | – | Sell |
-4,278
| Closed | -$248K | – | 652 |
|
|
2018
Q2 | $248K | Sell |
4,278
-5,450
| -56% | -$307K | 0.02% | 423 |
|
|
2018
Q1 | $506K | Buy |
9,728
+1,258
| +15% | +$67.9K | 0.04% | 266 |
|
|
2017
Q4 | $455K | Sell |
8,470
-105
| -1% | -$5.82K | 0.05% | 334 |
|
|
2017
Q3 | $524K | Sell |
8,575
-50,094
| -85% | -$3.04M | 0.06% | 337 |
|
|
2017
Q2 | $3.59M | Buy |
58,669
+41,710
| +246% | +$2.54M | 0.52% | 55 |
|
|
2017
Q1 | $1.03M | Buy |
+16,959
| New | +$1.03M | 0.2% | 170 |
|
|
2016
Q4 | – | Sell |
-13,396
| Closed | -$798K | – | 621 |
|
|
2016
Q3 | $798K | Buy |
+13,396
| New | +$783K | 0.23% | 154 |
|
|
2016
Q1 | – | Sell |
-505
| Closed | -$25K | – | 634 |
|
|
2015
Q4 | $25K | Buy |
+505
| New | +$25.5K | 0.02% | 478 |
|
|
2015
Q1 | – | Sell |
-3,335
| Closed | -$181K | – | 614 |
|
|
2014
Q4 | $181K | Buy |
3,335
+2,201
| +194% | +$123K | 0.3% | 128 |
|
|
2014
Q3 | $64.1K | Sell |
1,134
-6,812
| -86% | -$383K | 0.05% | 377 |
|
|
2014
Q2 | $439K | Buy |
+7,946
| New | +$433K | 0.42% | 61 |
|
Other funds holding MRK
Seven Eight Capital's MRK Position: Q4 2024 in Review
Seven Eight Capital sold out of Merck (MRK) in Q4 2024, closing a stake of 38,198 shares — an estimated $4.34M sold.
Seven Eight Capital first reported a position in MRK in Q2 2014 and held it in 23 quarters. The position peaked at $16.7M in Q2 2019. 3,608 funds tracked by Wall St. Rank hold MRK as of Q4 2024.
- Seven Eight Capital reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
- Seven Eight Capital sold 38,198 Merck shares in Q4 2024, an estimated $4.34M.
- Seven Eight Capital first reported a position in Merck in Q2 2014 and held it in 23 quarters.
- Seven Eight Capital's Merck position peaked at $16.7M in Q2 2019.
- 3,608 funds tracked by Wall St. Rank held Merck as of Q4 2024.
Based on Seven Eight Capital's 13F filing for Q4 2024.